Young-Jun Park Selected Research

Shiga Toxins (Vero Toxin)

11/2020	Exosomes released from Shiga toxin 2a-treated human macrophages modulate inflammatory responses and induce cell death in toxin receptor expressing human cells.
10/2017	Shiga Toxins Induce Apoptosis and ER Stress in Human Retinal Pigment Epithelial Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Young-Jun Park Research Topics

Disease

16	Neoplasms (Cancer) 11/2022 - 04/2009
13	Inflammation (Inflammations) 04/2024 - 10/2011
13	Infections 01/2024 - 10/2018
6	Human Influenza (Influenza) 12/2023 - 10/2018
6	COVID-19 01/2023 - 08/2020
6	Acute Lung Injury 08/2009 - 09/2007
5	Sepsis (Septicemia) 11/2021 - 09/2007
4	Colitis 01/2020 - 10/2010
3	Lung Injury 04/2024 - 09/2008
3	Virus Diseases (Viral Diseases) 09/2023 - 01/2022
3	Lung Diseases (Lung Disease) 03/2023 - 09/2008
3	Necrosis 01/2023 - 01/2019
3	Neoplasm Metastasis (Metastasis) 11/2022 - 01/2020
3	Obesity 06/2022 - 12/2017
3	Asthma (Bronchial Asthma) 01/2022 - 06/2017
2	Chronic Obstructive Pulmonary Disease (COPD) 04/2024 - 01/2022
2	Emphysema 04/2024 - 01/2020
2	Atherosclerosis 01/2023 - 01/2018
2	Breakthrough Infections 11/2022 - 08/2022
2	Lung Neoplasms (Lung Cancer) 11/2022 - 01/2022
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2018
2	Pneumonia (Pneumonitis) 01/2022 - 11/2007
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 12/2018
2	Melanoma (Melanoma, Malignant) 01/2020 - 07/2015
2	Thyroid Neoplasms (Thyroid Cancer) 06/2019 - 01/2018
2	Dyslipidemias (Dyslipidemia) 09/2018 - 01/2018
2	Stomach Neoplasms (Stomach Cancer) 10/2017 - 01/2016
2	Shock 08/2015 - 01/2013
2	Pulmonary Edema 08/2009 - 09/2008
1	Weight Loss (Weight Reduction) 12/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2023
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023
1	Atherosclerotic Plaque (Atheroma) 01/2023

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2013
11	VaccinesIBA 12/2023 - 11/2014
9	CytokinesIBA 04/2024 - 11/2007
6	Particulate MatterIBA 04/2024 - 01/2022
6	Glycoproteins (Glycoprotein)IBA 01/2024 - 03/2015
6	LipopolysaccharidesIBA 11/2021 - 04/2009
5	Neutralizing AntibodiesIBA 01/2023 - 01/2019
5	Monoclonal AntibodiesIBA 01/2023 - 08/2020
5	AntibodiesIBA 11/2022 - 10/2021
5	ThioredoxinsIBA 12/2020 - 01/2013
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021 - 09/2008
3	AntigensIBA 12/2023 - 10/2018
3	Hemagglutinins (Hemagglutinin)IBA 12/2023 - 01/2020
3	NanovaccinesIBA 12/2023 - 01/2021
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023 - 08/2009
3	EpitopesIBA 01/2023 - 01/2022
3	ginsenoside Rg3IBA 06/2022 - 12/2017
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2021 - 01/2013
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2021 - 01/2013
3	LigandsIBA 01/2019 - 01/2018
3	Interleukin-27 (Interleukin 27)IBA 01/2019 - 01/2018
3	AllergensIBA 01/2018 - 05/2010
3	NF-kappa B (NF-kB)IBA 01/2017 - 09/2007
3	Interleukin-6 (Interleukin 6)IBA 10/2014 - 09/2008
2	SmokeIBA 04/2024 - 01/2022
2	Peptides (Polypeptides)IBA 01/2023 - 08/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 08/2016
2	casirivimab and imdevimab drug combinationIBA 01/2023 - 01/2022
2	cilgavimabIBA 01/2023 - 01/2022
2	N-(2-cyanoethylene)urea (BA 1)IBA 11/2022 - 08/2022
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 11/2022 - 08/2022
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 11/2016
2	Virulence Factors (Pathogenicity Factors)IBA 11/2020 - 10/2017
2	Shiga Toxins (Vero Toxin)IBA 11/2020 - 10/2017
2	Peroxidase (Myeloperoxidase)IBA 01/2020 - 11/2007
2	Therapeutic UsesIBA 01/2020 - 12/2017
2	Toll-Like Receptor 4IBA 01/2018 - 01/2016
2	InflammasomesIBA 08/2015 - 01/2013
1	Caspase 1 (ICE Protease)IBA 04/2024
1	Serine Proteases (Serine Protease)IBA 01/2024
1	IronIBA 02/2023
1	ChemokinesIBA 01/2023
1	DefensinsIBA 01/2023
1	ChromatinIBA 01/2023
1	CholesterolIBA 01/2023
1	LuciferasesIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	ApolipoproteinsIBA 01/2023
1	Small Interfering RNA (siRNA)IBA 01/2023
1	Conditioned Culture MediaIBA 11/2022
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 11/2022
1	AntioxidantsIBA 06/2022
1	Neuraminidase (Sialidase)IBA 01/2022
1	Air Pollutants (Pollutants, Air)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 11/2021
1	AnisomycinIBA 11/2021
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 10/2021
1	C-Type Lectins (C-Type Lectin)IBA 10/2021
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 10/2021
1	Immunoglobulins (Immunoglobulin)IBA 10/2021
1	EnzymesIBA 10/2021
1	LectinsIBA 10/2021

Therapy/Procedure

4	Therapeutics 09/2023 - 06/2019
2	Lasers (Laser) 01/2023 - 06/2017
2	Ligation 11/2021 - 01/2019
2	Punctures 11/2021 - 01/2019
2	Immunotherapy 01/2021 - 01/2018